Revelation Biosciences, Inc.(REVB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REVB Revelation Biosciences, Inc.

盘前交易 02-26 04:49:41 EST

1.41

+0.06

+4.44%

最高1.41	最低1.32	成交量13.74万
今开1.32	昨收1.35	日振幅6.67%
总市值369.86万	流通市值81.92万	总股本262.31万
成交额18.89万	换手率23.65%	流通股本58.10万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"REVB","market":"US","secType":"STK","nameCN":"Revelation Biosciences, Inc.","latestPrice":1.41,"timestamp":1772053200000,"preClose":1.35,"halted":0,"volume":137393,"delay":0,"changeRate":0.044444444444444314,"floatShares":581000,"shares":2623100,"eps":-120.02,"marketStatus":"盘前交易","change":0.06,"latestTime":"02-26 04:49:41 EST","open":1.32,"high":1.41,"low":1.32,"amount":188893.1448126,"amplitude":0.066667,"askPrice":1.41,"askSize":225,"bidPrice":1.21,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-120.02,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772116200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":1.41,"postHourTrading":{"tag":"盘后","latestPrice":1.3527,"preClose":1.41,"latestTime":"19:47 EST","volume":15263,"amount":20924.9908,"timestamp":1772066852547,"change":-0.0573,"changeRate":-0.040638,"amplitude":0.056738},"volumeRatio":1.190754351721863},"requestUrl":"/m/hq/s/REVB","defaultTab":"news","newsList":[{"id":"2612446288","title":"Revelation Biosciences, Inc.盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612446288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612446288?lang=zh_cn&edition=full","pubTime":"2026-02-18 04:59","pubTimestamp":1771361964,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日04时59分，Revelation Biosciences, Inc.股票出现波动，股价大幅下跌5.44%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Polaryx Therapeutics, Inc.、Cibus, Inc.、Nautilus Biotechnology, Inc.涨幅较大，Ensysce Biosciences, Inc.、Moolec Science Sa、Polaryx Therapeutics, Inc.较为活跃，换手率分别为839.76%、120.06%、114.02%，振幅较大的相关个股有Polaryx Therapeutics, Inc.、Ensysce Biosciences, Inc.、Cibus, Inc.，振幅分别为81.33%、74.28%、40.65%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218045925a70525fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218045925a70525fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVBU","REVBW","REVB"],"gpt_icon":0},{"id":"2610952941","title":"Revelation Biosciences, Inc.盘中异动 股价大涨5.26%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610952941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610952941?lang=zh_cn&edition=full","pubTime":"2026-02-11 02:12","pubTimestamp":1770747174,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日02时12分，Revelation Biosciences, Inc.股票出现波动，股价快速拉升5.26%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Quince Therapeutics, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Phio Pharmaceuticals Corp.涨幅较大，Abpro Holdings, Inc、Quince Therapeutics, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为2488.96%、1823.75%、1344.76%，振幅较大的相关个股有Quince Therapeutics, Inc.、Abpro Holdings, Inc、Tuhura Biosciences, Inc.，振幅分别为169.08%、67.76%、50.61%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102125497a5aec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102125497a5aec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","REVB","REVBU","BK4139"],"gpt_icon":0},{"id":"2607273724","title":"Revelation Biosciences, Inc.盘中异动 早盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607273724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607273724?lang=zh_cn&edition=full","pubTime":"2026-01-28 22:32","pubTimestamp":1769610738,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日22时32分，Revelation Biosciences, Inc.股票出现异动，股价大幅下挫5.35%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 、Pds Biotechnology Corporation、Gri Bio, Inc.涨幅较大，Gri Bio, Inc.、60 Degrees Pharmaceuticals, Inc.、Calcimedica, Inc.较为活跃，换手率分别为1745.54%、111.08%、64.48%，振幅较大的相关个股有Gri Bio, Inc.、Regenxbio Inc.、Cingulate Inc.，振幅分别为13.16%、9.81%、8.15%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012822321897a3d06d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012822321897a3d06d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","REVBW","BK4139","REVBU"],"gpt_icon":0},{"id":"2601772008","title":"Revelation Biosciences, Inc.盘中异动 下午盘股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601772008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601772008?lang=zh_cn&edition=full","pubTime":"2026-01-07 03:39","pubTimestamp":1767728378,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日03时39分，Revelation Biosciences, Inc.股票出现异动，股价大幅上涨6.08%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Alumis Inc.、Cyclerion Therapeutics, Inc.、Acrivon Therapeutics, Inc.涨幅较大，Pmgc Holdings Inc.、Cyclerion Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为2398.35%、1780.02%、240.88%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.，振幅分别为297.37%、161.40%、84.56%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107033939953c19da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107033939953c19da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","BK4139","REVBW","REVBU"],"gpt_icon":0},{"id":"2587673152","title":"Revelation Biosciences, Inc.盘中异动 早盘股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587673152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587673152?lang=zh_cn&edition=full","pubTime":"2025-11-28 23:08","pubTimestamp":1764342518,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日23时08分，Revelation Biosciences, Inc.股票出现异动，股价急速上涨5.34%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。Gemini是Revelation的专有配方，为磷酸化的六酰二糖，是一种已知的TLR4激动剂，可以刺激人体的先天免疫反应以预防和治疗疾病。所开发的产品候选者均基于Gemini配方的PHAD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128230838a4c0b647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128230838a4c0b647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","REVBW","BK4139","REVBU"],"gpt_icon":0},{"id":"1132532915","title":"Revelation Biosciences, Inc. 第三季度每股收益为 -1.77 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132532915","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132532915?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:01","pubTimestamp":1763571671,"startTime":"0","endTime":"0","summary":"11月6日 - Revelation Biosciences, Inc. 第三季度净收入为 -190 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REVB"],"gpt_icon":0},{"id":"2583501146","title":"Revelation Biosciences, Inc.盘中异动 下午盘快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583501146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583501146?lang=zh_cn&edition=full","pubTime":"2025-11-14 02:01","pubTimestamp":1763056914,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日02时01分，Revelation Biosciences, Inc.股票出现异动，股价大幅下挫5.14%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Mersana Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、冠科美博涨幅较大，Clearmind Medicine Inc.、Salarius Pharmaceuticals, Inc.、Outlook Therapeutics, Inc.较为活跃，换手率分别为5233.34%、465.46%、94.61%，振幅较大的相关个股有Clearmind Medicine Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Outlook Therapeutics, Inc.，振幅分别为107.67%、45.96%、36.72%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114020154a6f79401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114020154a6f79401&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVBW","REVBU","REVB"],"gpt_icon":0},{"id":"2578573094","title":"Revelation Biosciences, Inc.盘中异动 股价大涨7.44%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578573094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578573094?lang=zh_cn&edition=full","pubTime":"2025-10-24 23:32","pubTimestamp":1761319974,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日23时32分，Revelation Biosciences, Inc.股票出现波动，股价快速上涨7.44%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Theriva Biologics, Inc.、Genenta Science Spa、Inhibrx Biosciences, Inc.涨幅较大，Neuphoria Therapeutics Inc.、Qualigen Therapeutics, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为3107.40%、2328.53%、1869.33%，振幅较大的相关个股有Theriva Biologics, Inc.、Genenta Science Spa、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.04%、133.75%、84.64%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102423325494dbdd93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102423325494dbdd93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","REVBU","REVB","BK4139"],"gpt_icon":0},{"id":"2566569768","title":"Revelation Biosciences, Inc.盘中异动 早盘大幅下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566569768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566569768?lang=zh_cn&edition=full","pubTime":"2025-09-08 21:33","pubTimestamp":1757338386,"startTime":"0","endTime":"0","summary":"北京时间2025年09月08日21时33分，Revelation Biosciences, Inc.股票出现异动，股价快速下跌5.20%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Rapport Therapeutics, Inc.、Genprex, Inc.、Ethzilla Corporation C/Wts 06/11/2025涨幅较大，Cdt Equity Inc.、Genprex, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为710.17%、95.21%、63.11%，振幅较大的相关个股有Rapport Therapeutics, Inc.、Genprex, Inc.、Alphaton Capital Corp.，振幅分别为29.72%、24.75%、11.59%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090821330697813eb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090821330697813eb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","REVB","REVBW","BK4139"],"gpt_icon":0},{"id":"2518206835","title":"Revelation Biosciences, Inc.盘中异动 下午盘大幅下挫5.44%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518206835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518206835?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:41","pubTimestamp":1741628510,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时41分，Revelation Biosciences, Inc.股票出现波动，股价快速下挫5.44%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014150964067e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014150964067e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVB","REVBU","REVBW"],"gpt_icon":0},{"id":"2518811592","title":"Revelation Biosciences, Inc.2024财年实现净利润-15.04百万美元，同比减少12406.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518811592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518811592?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536087,"startTime":"0","endTime":"0","summary":"3月10日，Revelation Biosciences, Inc.公布财报，公告显示公司2024财年净利润为-15.04百万美元，同比减少12406.86%；其中营业收入为0.00美元，每股基本收益为-87.68美元。机构评级：截至2025年3月10日，当前有2家机构对Revelation Biosciences, Inc.目标价做出预测，其中目标均价为170.72美元，其中最低目标价为21.45美元，最高目标价为320.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000315a26898a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000315a26898a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","REVBU","REVBW"],"gpt_icon":0},{"id":"1134026864","title":"Revelation生物技术公司第四季度每股收益为$-4.98","url":"https://stock-news.laohu8.com/highlight/detail?id=1134026864","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134026864?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:30","pubTimestamp":1741296640,"startTime":"0","endTime":"0","summary":"Revelation生物技术公司第四季度每股收益为$-4.98以上内容来自Benzinga Earnings专栏，原文如下：Revelation Biosciences Q4 EPS $(4.98)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REVB"],"gpt_icon":0},{"id":"2516603819","title":"Revelation Biosciences, Inc.盘中异动 大幅下挫7.16%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516603819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516603819?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:15","pubTimestamp":1741101319,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时15分，Revelation Biosciences, Inc.股票出现波动，股价大幅下跌7.16%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231520a25f1216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231520a25f1216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","REVBW","REVB","BK4139"],"gpt_icon":0},{"id":"2516650984","title":"Revelation Biosciences, Inc.盘中异动 快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516650984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516650984?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:31","pubTimestamp":1741030280,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时31分，Revelation Biosciences, Inc.股票出现异动，股价大幅上涨5.13%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4544.75%、206.64%、181.12%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033121989a51ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033121989a51ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","BK4139","REVBW","REVB"],"gpt_icon":0},{"id":"2514581376","title":"Revelation Biosciences, Inc.盘中异动 早盘股价大跌5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514581376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514581376?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:36","pubTimestamp":1740756992,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时36分，Revelation Biosciences, Inc.股票出现异动，股价急速下挫5.79%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1717.03%、413.65%、345.93%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、41.62%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282336329896884b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282336329896884b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","BK4139","REVBW","REVBU"],"gpt_icon":0},{"id":"2514386763","title":"Revelation Biosciences, Inc.盘中异动 早盘快速下跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386763?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:00","pubTimestamp":1740668450,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时00分，Revelation Biosciences, Inc.股票出现波动，股价快速下挫5.55%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230050abdf767f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230050abdf767f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","REVBW","BK4139","REVBU"],"gpt_icon":0},{"id":"2514665016","title":"Revelation Biosciences, Inc.盘中异动 早盘股价大跌6.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514665016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514665016?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:35","pubTimestamp":1740497733,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时35分，Revelation Biosciences, Inc.股票出现异动，股价急速跳水6.70%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1077.24%、598.25%、563.92%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为64.05%、61.16%、60.87%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233533a253965b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233533a253965b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","BK4139","REVB","REVBU"],"gpt_icon":0},{"id":"2513720987","title":"Revelation Biosciences, Inc.盘中异动 股价大跌6.50%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720987?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:58","pubTimestamp":1740409131,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时58分，Revelation Biosciences, Inc.股票出现波动，股价急速下挫6.50%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225851962e9f98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225851962e9f98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVBU","REVBW","REVB"],"gpt_icon":0},{"id":"2512161262","title":"Revelation Biosciences, Inc.盘中异动 早盘急速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512161262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512161262?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:37","pubTimestamp":1739893024,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时37分，Revelation Biosciences, Inc.股票出现异动，股价大幅拉升5.14%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为366.61%、162.38%、138.79%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233704a24abbd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233704a24abbd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","BK4139","REVBW","REVBU"],"gpt_icon":0},{"id":"2511069139","title":"Revelation Biosciences, Inc.盘中异动 股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511069139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511069139?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:59","pubTimestamp":1739545142,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时59分，Revelation Biosciences, Inc.股票出现波动，股价大幅上涨5.53%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2109.24%、541.49%、445.01%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、40.35%、33.28%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225902abcf0ce0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225902abcf0ce0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVBU","REVBW","REVB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revbiosciences.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.3592},{"period":"3month","weight":-0.622},{"period":"6month","weight":-0.8723},{"period":"1year","weight":-0.969},{"period":"ytd","weight":-0.5593}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revelation Biosciences, Inc.是一家特拉华州公司，成立于2019年11月20日。该公司是一家临床阶段的生命科学公司，专注于开发用于预防和治疗疾病的免疫疗法。Revelation有几个正在开发的候选产品。REVTx-99是主要的治疗候选药物，是一种鼻内免疫调节剂，用于预防或治疗由各种呼吸道病毒引起的感染。REVTx-99也正在开发用于其他适应症，例如：过敏性鼻炎和慢性鼻塞。REVTx-200是一种鼻内免疫调节剂辅助剂，可与肌肉注射疫苗联合使用，以获得更完全的免疫。Revelation还在开发REVDx-501，这是一种快速的家用诊断工具，可用于检测任何呼吸道病毒感染，无需专门的仪器。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.239557},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.370958},{"month":3,"riseRate":0,"avgChangeRate":-0.210884},{"month":4,"riseRate":0.4,"avgChangeRate":-0.080222},{"month":5,"riseRate":0,"avgChangeRate":-0.257093},{"month":6,"riseRate":0.4,"avgChangeRate":0.177022},{"month":7,"riseRate":0.2,"avgChangeRate":-0.130551},{"month":8,"riseRate":0.4,"avgChangeRate":-0.132636},{"month":9,"riseRate":0.4,"avgChangeRate":-0.212261},{"month":10,"riseRate":0.6,"avgChangeRate":-0.028205},{"month":11,"riseRate":0.4,"avgChangeRate":-0.088914},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.150121}],"exchange":"NASDAQ","name":"Revelation Biosciences, Inc.","nameEN":"Revelation Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revelation Biosciences, Inc.(REVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revelation Biosciences, Inc.(REVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revelation Biosciences, Inc.,REVB,Revelation Biosciences, Inc.股票,Revelation Biosciences, Inc.股票老虎,Revelation Biosciences, Inc.股票老虎国际,Revelation Biosciences, Inc.行情,Revelation Biosciences, Inc.股票行情,Revelation Biosciences, Inc.股价,Revelation Biosciences, Inc.股市,Revelation Biosciences, Inc.股票价格,Revelation Biosciences, Inc.股票交易,Revelation Biosciences, Inc.股票购买,Revelation Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revelation Biosciences, Inc.(REVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revelation Biosciences, Inc.(REVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}